RYDAPT
As listed in the register: RYDAPT 25 mg, capsule molle
25 mg · capsule molle
- Prescription only
- Active substance
- Midostaurine
- Made by
- NOVARTIS EUROPHARM (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Details
| Made by | NOVARTIS EUROPHARM (IRLANDE) |
|---|---|
| Active substance | Midostaurine |
| Strength | 25 mg |
| Form | capsule molle |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription réservée aux spécialistes et services DERMATOLOGIE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en maladie du sang · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/17/1218 |
| Name in the register | RYDAPT 25 mg, capsule molle |
| Packs | Conditionnements multiples de 112 (4 boîtes de 28) capsules sous plaquettes polyamide aluminium PVC-Aluminium · Conditionnements multiples de 56 (2 boîtes de 28) capsules sous plaquettes polyamide aluminium PVC-Aluminium |
| CIS | 67868413 |
| CIP13 | 3400930113608 |
| CIP13 | 3400930129821 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).